Kirk V. Shepard
CIK: 0002009007
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PDSB
PDS Biotechnology Corp
Officer
Discretionary Trading P&L
Holdings
About Shepard Kirk V.
Shepard Kirk V. (SEC CIK 0002009007) files insider reports with the SEC as Chief Medical Officer of PDS Biotechnology Corp (PDSB).
Signal8 holds 2 ownership filings by Shepard Kirk V., all Form 4s, filed between Jul 25, 2025 and Mar 3, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jan 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shepard Kirk V.'s filings is in PRINCETON, NJ.
Recent filings by Shepard Kirk V.
Other insiders filing for PDS Biotechnology Corp (PDSB)
- Dawson John Andrew, Director
- Ramsdell Deborah, Director
- Wendel Bruce, Director
- SOON-SHIONG PATRICK, Director
- Banaag Arnold James, Director
- Trochimiuk Janetta, Principal Accounting Officer